Fighting diseases of global impact
The Institute for Glycomics, founded 20 years ago, was so named due to its multidisciplinary research approach centred around glycomics.
Our unique research expertise makes us the only institute of its kind in Australia and only one of a handful in the world. We seek to collaborate with leading scientists around the world to build a critical mass around this multidisciplinary research. Global collaboration is essential to achieving our vision to bring forward novel drugs and vaccines to the community.
Welcome to the Institute for Glycomics
What is glycomics?
Glycomics is the study of the carbohydrate or sugar language within our body, referred to as the ‘glycome’. Every cell in our body is decorated with these sugars, which are essential to our health and wellbeing.
These simple sugar molecules connect together to create powerful structures called ‘glycans’. Cancers and infectious diseases can take advantage of glycans, resulting in major health problems and potentially death.
The study of sugars – glycomics – is a relatively new field of study compared with genomics (the study of genes) and proteomics (the study of proteins). However, glycomics is now a rising star thanks to the development of new tools to effectively identify sugar structures and their involvement in disease.
Our research focusses on the role that sugars play in disease and, using that knowledge, invent new drugs, vaccines and diagnostics to treat, prevent or diagnose cancer and infectious diseases.
“To be a world-leader in the discovery and development of drugs, vaccines and diagnostics through the application of innovative multidisciplinary science in a unique research environment.”
“Fighting diseases of global impact through discovery and translational science.”
A major research theme is discovering the role that sugars/carbohydrates play in disease and use that knowledge to develop new drugs and vaccines which will interfere with the biological process of disease. We provide a multidisciplinary approach to research and education, spanning medicinal and computational chemistry, various biological and physical sciences. This approach presents an exciting platform for the control of a wide-range of medical conditions such as infectious disease, cancer and other disorders.
Celebrating 20 years
2020 marks our 20th Anniversary year: 20 years of remarkable research
Professor von Itzstein Gold Coast Citizen of the Year
24 Jan 2020
Director and Head of Research for the Institute for Glycomics Professor Mark von Itzstein AO has...
New treatment for viral arthritis reveals impressive results in Phase 2 human...
19 Dec 2019
Human clinical trial success of new drug candidate to treat viral arthritis caused by...
Meningococcal vaccine may reduce gonorrhoea incidence
10 Dec 2019
A world-first trial for a promising gonorrhoea vaccine will be led by Griffith University’s...
Griffith awarded $3.3 million in funding for ARC Discovery and Linkage projects
05 Dec 2019
Griffith University has been awarded $3,376,073 for ARC Discovery and Linkage Projects.
Griffith and China Grand Pharma sign landmark deal to develop new drug for...
04 Dec 2019
Griffith’s Institute for Glycomics has partnered with China Grand Pharma’s new Australian...
Researchers use deep learning method to delve into predicting RNA structures in...
28 Nov 2019
Method to better predict RNA secondary structures could become tool to better understand...